Genetic study predicts success of ATR inhibitors in rare cancer
Scientists at The Institute of Cancer Research, London, have identified a gene that affects how ovarian clear cell carcinoma (OCCC) could respond to a new class of drug called ATR inhibitors. In clinical trials, ATR inhibitors have demonstrated efficacy as a treatment for various types of cancer,… Read More
